forecast glp-1 prescriptions growth 2025 drugs are rewriting America's food preferences, says IFF GLP-1s in 2025: Who's Using

Registry data suggest that prolonged use of GLP-1 receptor agonists is linked to improved clinical outcomes such as a greater decrease in hemoglobin A1c (HbA1c) [5]

Nevertheless, it was demonstrated that inadequate weight loss after BS is often associated with increased appetite and an unfavorable postoperative gut hormone profile, including reduced circulating GLP-1 levels [25, 26]

Patients with heart failure, kidney disease, or other conditions requiring fluid restriction should consult their healthcare provider for personalized hydration targets

longer-term durability beyond that timeframe remains under study

Individuals with diabetes generally experience less weight reduction with GLP-1 RAs than those without diabetes [2, 6]

Telemedicine is not just about convenience its about compliance